Stocks
GlaxoSmithKline (GSK) CAPEX US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX, £ | ? | 2 931 000 000 | 2 258 000 000 | 2 258 000 000 | 2 344 000 000 | 2 344 000 000 | 2 626 000 000 | ||
| Changes by years, y/y, % | 0% | -23% | 0% | +4% | 0% | +5.5% | |||
GlaxoSmithKline. CAPEX, £
GlaxoSmithKline. CAPEX, changes, %
GlaxoSmithKline. CAPEX, sum by quarters, £
GlaxoSmithKline (GSK) CAPEX US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| CAPEX, £ | ? | 535 000 000 | 497 000 000 | 783 000 000 | 783 000 000 | 563 000 000 | 2 626 000 000 | |
| Changes by years, y/y, % | +26% | +4% | +4% | +4% | +6% | |||
| Changes by quarters, q/q, % | 0% | -7% | +58% | 0% | -28% | |||
